A shocking allegation has emerged, accusing the Biden administration of concealing vital information about the Covid vaccines. But is this claim justified, or is it a controversial twist in the vaccine narrative? Let's unravel the facts.
FDA Commissioner's Accusation:
The FDA chief, Marty Makary, has made a startling claim: the Biden administration withheld data on the risk of myocarditis, a heart condition, associated with the Covid vaccine. This accusation contradicts years of transparency from federal health officials.
Makary asserts that the FDA has thoroughly investigated myocarditis cases and reviewed deaths related to the Covid vaccine. He alleges that the Biden administration had access to internal data on myocarditis in young people but chose not to disclose it to the public.
Vaccine Regulator's Memo:
Adding fuel to the fire, the FDA's vaccine regulator, Vinay Prasad, recently sent a memo to staff, stating that at least 10 children died after receiving the Covid vaccine, possibly due to myocarditis. However, Prasad's claim lacks supporting evidence, leaving room for skepticism.
Myocarditis and Covid Vaccines:
Myocarditis, an inflammation of the heart muscle, is a known, albeit small, risk associated with the mRNA Covid vaccines from Pfizer and Moderna. Federal agencies have been transparent about this information since 2021.
FDA's Silence and Former Leaders' Criticism:
Interestingly, the FDA has not released its new findings publicly or published them in peer-reviewed journals. This silence has drawn criticism from former FDA leaders, who issued a scathing statement denouncing the agency's recent assertions.
Myocarditis Link to Covid Vaccines:
The potential link between myocarditis and Covid vaccines first surfaced in March 2021, with reports from the U.S. and Israel citing rare cases post-vaccination. Symptoms include shortness of breath, chest pain, and heart palpitations.
CDC's Response and Advisory Group's Discussion:
In May 2021, the CDC's vaccine safety group acknowledged reviewing reports of heart inflammation in young people, coinciding with the authorization of Pfizer's Covid vaccine for teens. A month later, the CDC's advisory group publicly discussed the issue, concluding that while there was a likely association between myocarditis and the vaccines, the benefits of vaccination outweighed the risks.
FDA's Warning and Official's Rebuttal:
The FDA eventually added a warning about myocarditis to the fact sheets for Pfizer and Moderna vaccines in June 2021. However, a senior health official from the Biden administration dismissed Makary's claim as 'absurd' and argued that it would damage public trust in the FDA. The official denied any pressure from the White House and emphasized the transparency of adverse event reporting and product approval processes.
Public Meetings and Data Availability:
Since the Covid vaccines' approval in late 2020, the federal government has held numerous public meetings to review vaccine data and published several papers on myocarditis risk. Dr. Ofer Levy, a former member of the FDA's advisory group, confirmed the availability of data and briefing documents online for public access.
Makary's Investigation and Lack of Details:
Makary's investigation into child deaths involves reaching out to families and reviewing autopsies. He claims these children died immediately after vaccination and developed myocarditis or other serious complications. However, Makary provides no further details about the children's ages, medical histories, or Covid diagnoses, leaving these crucial aspects unexplained.
FDA's New Claims and Evidence Discrepancy:
The FDA's new claims about child deaths contradict the existing evidence on vaccine-associated myocarditis. Studies show that the highest risk is among teen and young adult males, especially within days after the second dose of mRNA vaccines. A CDC report from 2021 found higher rates among younger males, with most cases being mild and resolving quickly. Notably, no deaths from myocarditis have been confirmed to be linked to the Covid vaccines.
Controversy and Comment:
This revelation raises questions about the FDA's handling of vaccine safety data. Was the Biden administration truly withholding information, or is there more to the story? Should the public be concerned about the transparency of vaccine-related data? Share your thoughts and join the discussion in the comments below. Let's explore the complexities of vaccine safety and transparency together.
